Who owns Unither Pharmaceuticals?

Unither Pharmaceuticals is currently owned by IK Partners, through IK Partnership Fund II, since 2023.

When did IK Partners acquire Unither Pharmaceuticals?

IK Partners acquired Unither Pharmaceuticals in 2023 (active for 3 years).

Home/Companies/Healthcare/Unither Pharmaceuticals

Unither Pharmaceuticals

Healthcare·

France·Active·3yr hold

Unither Pharmaceuticals is a healthcare company, headquartered in France.

Entry

2023

Hold

3yr

Status

Active

Est. EV

–

Most recent investor

IK Partners

4 ownership periods

Key facts

HQFrance

SectorHealthcare

French CDMO world leader in BFS. 1,500 employees, 8 plants (FR/US/BR/CN). CA €371M (2022), target €500M. Consortium with GIC + Keensight

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

6 verified KPIs (Revenue, EBITDA, growth)

3 source links for every datapoint

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from IK Partnership Fund II

Other portfolio companies in the same fund.

GEDH (Groupe Européen de Données de l'Habitat)

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Last updated April 2026 · Sourced from public filings